Afy Okoye is a San Francisco-based columnist at Health Stack, where she covers AI, policy, and innovation. With over eight years of experience managing global drug launches for leading pharmaceutical brands and developing value-based payment strategies, she brings a practical perspective on how innovation and policy shapes payers, clinicians, and corporations. She currently leads marketing for one of the first companies using generative AI to pioneer de novo drug design and engineer novel therapeutics from scratch. Afy holds a M.S. in International Health Policy and Economics from the London School of Economics and dual B.A. degrees in Journalism and Political Science from Georgia State University. A lifelong learner, she spends her free time uncovering hidden stories, writing creative prose, and adventuring with her spunky schnauzer. You can connect with her on LinkedIn.
